Top

Journal of Translational Medicine

Published in:

01-12-2020 | Obesity | Research

The impact and distinction of ‘lipid healthy but obese’ and ‘lipid abnormal but not obese’ phenotypes on lumbar disc degeneration in Chinese

Authors: Sheng Shi, Zhi Zhou, Jun-Jun Liao, Yue-Hua Yang, Jun-Song Wu, Shuang Zheng, Shi-Sheng He

Published in: Journal of Translational Medicine | Issue 1/2020

Abstract

Background

Lipid abnormality and obesity have been proposed to be associated with lumbar disc degeneration, but little is known about the effect of ‘lipid healthy but obese’ (LH-O) and ‘lipid abnormal but not obese’ (LA-NO) phenotypes on lumbar disc degeneration in Chinese. The study aims to determine the impact and distinction of LH-O and LA-NO phenotypes on lumbar disc degeneration in Chinese, and to identify the association of related factors with risk of lumbar disc degeneration.

Methods

A total of 678 individuals were included with lumbar magnetic resonance imaging, serum lipid levels and anthropometric measurements. Obesity was defined on the basis of body mass index or waist to hip ratio (WHR). Pfirrmann score and Weishaupt’s scale were utilized to assess the degree of disc degeneration and facet joint degeneration.

Results

The incidence of the LH-O and LA-NO phenotypes were 11.4% and 18.1%, respectively. LA-NO phenotype demonstrates a high incidence for disc degeneration (P < 0.05), while LH-O phenotype confers a severe disc degeneration grade (P < 0.05). No statistical difference in the percentage of severe facet joint degeneration grade in each group (P > 0.05). Elevated triglycerides and greater WHR may be the risk factors for lumbar disc degeneration in Chinese.

Conclusion

LH-O and LA-NO phenotypes are common with different status of disc degeneration in Chinese. Elevated triglycerides and abdominal obesity appear to play crucial roles in the development of lumbar disc degeneration.

Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–47. https://doi.org/10.1016/S0140-6736(16)30970-9.CrossRefPubMed

Cheung JPY, Luk KDK. The relevance of high-intensity zones in degenerative disc disease. Int Orthop. 2019;43(4):861–7. https://doi.org/10.1007/s00264-018-4260-9.CrossRefPubMed

van den Berg R, Jongbloed LM, Kuchuk NO, Roorda LD, Oostveen JCM, Koes BW, Oei EHG, Bierma-Zeinstra SMA, Luijsterburg PAJ. The association between self-reported low back pain and radiographic lumbar disc degeneration of the cohort hip and cohort knee (CHECK) study. Spine. 2017;42(19):1464–71. https://doi.org/10.1097/BRS.0000000000002228.CrossRefPubMed

Buser Z, Chung AS, Abedi A, Wang JC. The future of disc surgery and regeneration. Int Orthop. 2019;43(4):995–1002. https://doi.org/10.1007/s00264-018-4254-7.CrossRefPubMed

Segar AH, Fairbank JCT, Urban J. Leptin and the intervertebral disc: a biochemical link exists between obesity, intervertebral disc degeneration and low back pain-an in vitro study in a bovine model. Eur Spine J. 2019;28(2):214–23. https://doi.org/10.1007/s00586-018-5778-7.CrossRefPubMed

Flouzat-Lachaniette CH, Jullien N, Bouthors C, Beohou E, Laurent B, Bierling P, Dubory A, Rouard H. A novel in vivo porcine model of intervertebral disc degeneration induced by cryoinjury. Int Orthop. 2018;42(9):2263–72. https://doi.org/10.1007/s00264-018-3971-2.CrossRefPubMed

Migliorini F, Rath B, Tingart M, Baroncini A, Quack V, Eschweiler J. Autogenic mesenchymal stem cells for intervertebral disc regeneration. Int Orthop. 2019;43(4):1027–36. https://doi.org/10.1007/s00264-018-4218-y.CrossRefPubMed

Sun Y, Leung VY, Cheung KM. Clinical trials of intervertebral disc regeneration: current status and future developments. Int Orthop. 2019;43(4):1003–10. https://doi.org/10.1007/s00264-018-4245-8.CrossRefPubMed

Li X, Wang X, Hu Z, Chen Z, Li H, Liu X, Yong ZY, Wang S, Wei Z, Han Y, Tan J, Li C, He XB, Sun G, Wu D, Li L. Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation. Sci Rep. 2017;7(1):7403. https://doi.org/10.1038/s41598-017-07780-x.CrossRefPubMedPubMedCentral

10.

Zhang Y, Zhao Y, Wang M, Si M, Li J, Hou Y, Jia J, Nie L. Serum lipid levels are positively correlated with lumbar disc herniation—a retrospective study of 790 Chinese patients. Lipids Health Dis. 2016;15:80. https://doi.org/10.1186/s12944-016-0248-x.CrossRefPubMedPubMedCentral

11.

Cannata F, Vadala G, Ambrosio L, Fallucca S, Napoli N, Papalia R, Pozzilli P, Denaro V. Intervertebral disc degeneration: a focus on obesity and type 2 diabetes. Diabetes Metab Res Rev. 2019. https://doi.org/10.1002/dmrr.3224.CrossRefPubMed

12.

Liu C, Yang H, Gao F, Li X, An Y, Wang J, Jin A. Resistin promotes intervertebral disc degeneration by upregulation of ADAMTS-5 through p38 MAPK signaling pathway. Spine. 2016;41(18):1414–20. https://doi.org/10.1097/BRS.0000000000001556.CrossRefPubMed

13.

Bell CG. The epigenomic analysis of human obesity. Obesity. 2017;25(9):1471–81. https://doi.org/10.1002/oby.21909.CrossRefPubMed

14.

Stefan N, Haring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152–62. https://doi.org/10.1016/S2213-8587(13)70062-7.CrossRefPubMed

15.

Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol. 2010;21(1):38–43. https://doi.org/10.1097/MOL.0b013e3283346ccc.CrossRefPubMed

16.

Lee SH, Ha HS, Park YJ, Lee JH, Yim HW, Yoon KH, Kang MI, Lee WC, Son HY, Park YM, Kwon HS. Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin Endocrinol. 2011;75(4):475–81. https://doi.org/10.1111/j.1365-2265.2011.04085.x.CrossRef

17.

Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E. Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord. 1999;23(12):1307–13. https://doi.org/10.1038/sj.ijo.0801072.CrossRefPubMed

18.

Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91(8):2906–12. https://doi.org/10.1210/jc.2006-0594.CrossRefPubMed

19.

Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes. 2007;31(1):177–88. https://doi.org/10.1038/sj.ijo.0803354.CrossRef

20.

Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature. Eur J Clin Nutr. 2010;64(1):16–22. https://doi.org/10.1038/ejcn.2009.68.CrossRefPubMed

21.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53. https://doi.org/10.1002/(sici)1096-9136(199807)15:7%3c539:aid-dia668%3e3.0.co;2-s.CrossRefPubMed

22.

Scicali R, Rosenbaum D, Di Pino A, Giral P, Cluzel P, Redheuil A, Piro S, Rabuazzo AM, Purrello F, Bruckert E, Gallo A. An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol. 2018;55(7):741–9. https://doi.org/10.1007/s00592-018-1144-9.CrossRefPubMed

23.

Baila-Rueda L, Lamiquiz-Moneo I, Jarauta E, Mateo-Gallego R, Perez-Calahorra S, Marco-Benedi V, Bea AM, Cenarro A, Civeira F. Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia. J Transl Med. 2018;16(1):6. https://doi.org/10.1186/s12967-018-1380-3.CrossRefPubMedPubMedCentral

24.

Esfandiar Z, Hosseini-Esfahani F, Mirmiran P, Habibi-Moeini AS, Azizi F. Red meat and dietary iron intakes are associated with some components of metabolic syndrome: tehran lipid and glucose study. J Transl Med. 2019;17(1):313. https://doi.org/10.1186/s12967-019-2059-0.CrossRefPubMedPubMedCentral

25.

Huang X, Jiang X, Wang L, Chen L, Wu Y, Gao P, Hua F. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study. J Transl Med. 2019;17(1):341. https://doi.org/10.1186/s12967-019-2074-1.CrossRefPubMedPubMedCentral

26.

Liu D, Chu X, Wang H, Dong J, Ge SQ, Zhao ZY, Peng HL, Sun M, Wu LJ, Song MS, Guo XH, Meng Q, Wang YX, Lauc G, Wang W. The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia. J Transl Med. 2018;16(1):235. https://doi.org/10.1186/s12967-018-1616-2.CrossRefPubMedPubMedCentral

27.

Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26(17):1873–8. https://doi.org/10.1097/00007632-200109010-00011.CrossRefPubMed

28.

Kettler A, Wilke HJ. Review of existing grading systems for cervical or lumbar disc and facet joint degeneration. Eur Spine J. 2006;15(6):705–18. https://doi.org/10.1007/s00586-005-0954-y.CrossRefPubMed

29.

Shi S, Liu ZD, Li XF, Qian L, Zhong GB, Chen FJ. Comparison of plate-cage construct and stand-alone anchored spacer in the surgical treatment of three-level cervical spondylotic myelopathy: a preliminary clinical study. Spine J. 2015;15(9):1973–80. https://doi.org/10.1016/j.spinee.2015.04.024.CrossRefPubMed

30.

Chen Y, Peng Q, Yang Y, Zheng S, Wang Y, Lu W. The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study. BMC Public Health. 2019;19(1):1293. https://doi.org/10.1186/s12889-019-7633-0.CrossRefPubMedPubMedCentral

31.

Shi S, Wang C, Yuan W, Wang X, Zhou X. Potential prevention: orally administered statins may retard the pathologic process of disc degeneration. Med Hypotheses. 2011;76(1):125–7. https://doi.org/10.1016/j.mehy.2010.08.050.CrossRefPubMed

32.

Rodriguez-Martinez NG, Perez-Orribo L, Kalb S, Reyes PM, Newcomb AG, Hughes J, Theodore N, Crawford NR. The role of obesity in the biomechanics and radiological changes of the spine: an in vitro study. J Neurosurg Spine. 2016;24(4):615–23. https://doi.org/10.3171/2015.7.SPINE141306.CrossRefPubMed

33.

Teraguchi M, Yoshimura N, Hashizume H, Yamada H, Oka H, Minamide A, Nagata K, Ishimoto Y, Kagotani R, Kawaguchi H, Tanaka S, Akune T, Nakamura K, Muraki S, Yoshida M. Progression, incidence, and risk factors for intervertebral disc degeneration in a longitudinal population-based cohort: the Wakayama Spine Study. Osteoarthr Cartil. 2017;25(7):1122–31. https://doi.org/10.1016/j.joca.2017.01.001.CrossRef

34.

Samartzis D, Karppinen J, Mok F, Fong DY, Luk KD, Cheung KM. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am. 2011;93(7):662–70. https://doi.org/10.2106/JBJS.I.01568.CrossRefPubMed

35.

Xu X, Li X, Wu W. Association between overweight or obesity and lumbar disk diseases: a meta-analysis. J Spinal Disord Tech. 2015;28(10):370–6. https://doi.org/10.1097/BSD.0000000000000235.CrossRefPubMed

36.

Teraguchi M, Yoshimura N, Hashizume H, Muraki S, Yamada H, Oka H, Minamide A, Ishimoto Y, Nagata K, Kagotani R, Tanaka S, Kawaguchi H, Nakamura K, Akune T, Yoshida M. Metabolic syndrome components are associated with intervertebral disc degeneration: the Wakayama Spine Study. PLoS ONE. 2016;11(2):e0147565. https://doi.org/10.1371/journal.pone.0147565.CrossRefPubMedPubMedCentral

37.

Varlotta GP, Lefkowitz TR, Schweitzer M, Errico TJ, Spivak J, Bendo JA, Rybak L. The lumbar facet joint: a review of current knowledge: part 1: anatomy, biomechanics, and grading. Skelet Radiol. 2011;40(1):13–23. https://doi.org/10.1007/s00256-010-0983-4.CrossRef

38.

Jaumard NV, Welch WC, Winkelstein BA. Spinal facet joint biomechanics and mechanotransduction in normal, injury and degenerative conditions. J Biomech Eng. 2011;133(7):071010. https://doi.org/10.1115/1.4004493.CrossRefPubMed

39.

Fujiwara A, Tamai K, Yamato M, An HS, Yoshida H, Saotome K, Kurihashi A. The relationship between facet joint osteoarthritis and disc degeneration of the lumbar spine: an MRI study. Eur Spine J. 1999;8(5):396–401. https://doi.org/10.1007/s005860050193.CrossRefPubMedPubMedCentral

40.

Zhang X, Chen J, Huang B, Wang J, Shan Z, Liu J, Chen Y, Li S, Fan S, Zhao F. Obesity mediates apoptosis and extracellular matrix metabolic imbalances via MAPK pathway activation in intervertebral disk degeneration. Front Physiol. 2019;10:1284. https://doi.org/10.3389/fphys.2019.01284.CrossRefPubMedPubMedCentral

41.

Leino-Arjas P, Kaila-Kangas L, Solovieva S, Riihimaki H, Kirjonen J, Reunanen A. Serum lipids and low back pain: an association? A follow-up study of a working population sample. Spine. 2006;31(9):1032–7. https://doi.org/10.1097/01.brs.0000214889.31505.08.CrossRefPubMed

42.

Leino-Arjas P, Kauppila L, Kaila-Kangas L, Shiri R, Heistaro S, Heliovaara M. Serum lipids in relation to sciatica among Finns. Atherosclerosis. 2008;197(1):43–9. https://doi.org/10.1016/j.atherosclerosis.2007.07.035.CrossRefPubMed

43.

Longo UG, Denaro L, Spiezia F, Forriol F, Maffulli N, Denaro V. Symptomatic disc herniation and serum lipid levels. Eur Spine J. 2011;20(10):1658–62. https://doi.org/10.1007/s00586-011-1737-2.CrossRefPubMedPubMedCentral

44.

Takatalo J, Karppinen J, Taimela S, Niinimaki J, Laitinen J, Sequeiros RB, Samartzis D, Korpelainen R, Nayha S, Remes J, Tervonen O. Association of abdominal obesity with lumbar disc degeneration—a magnetic resonance imaging study. PLoS ONE. 2013;8(2):e56244. https://doi.org/10.1371/journal.pone.0056244.CrossRefPubMedPubMedCentral

Title: The impact and distinction of ‘lipid healthy but obese’ and ‘lipid abnormal but not obese’ phenotypes on lumbar disc degeneration in Chinese
Authors: Sheng Shi
Zhi Zhou
Jun-Jun Liao
Yue-Hua Yang
Jun-Song Wu
Shuang Zheng
Shi-Sheng He
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Obesity
Obesity
Published in: Journal of Translational Medicine / Issue 1/2020
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-020-02382-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass

Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience

Assessment of scalability and performance of the record linkage tool E-PIX® in managing multi-million patients in research projects at a large university hospital in Germany

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

Can prospective systematic reviews of animal studies improve clinical translation?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials